| 000 | 01291nam a22003131a 4500 | ||
|---|---|---|---|
| 001 | vtls000251235 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250616035913.0 | ||
| 020 | _a 9283212762 | ||
| 039 |
_y 200805141413 _z 910 |
||
| 040 | _aUG-KaMUL | ||
| 060 |
_a QZ 202 _b In8s 2000 |
||
| 110 | _a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . | ||
| 245 |
_aSome antiviral and antineoplastic drugs, and other pharmaceutical ag ents / _c IARC Working Group on the Evaluation of Carcinogenic Risks t o Humans (2000 : Lyon, France) _b |
||
| 260 |
_aLyon : _bInternational Agency for Research Cancer ; World Health Or ganization, _c2000. |
||
| 300 |
_a iv, 521 p. : _b ill. ; _c 24 cm. |
||
| 440 |
_a IARC monographs on the evaluation of carcinogenic risks to humans ; _v v. 76 |
||
| 504 | _a Includes bibliographical references and index. | ||
| 650 |
_aCarcinogens _xadverse effects _v _y _z |
||
| 650 |
_aAntiviral Agents _xadverse effects _v _y _z |
||
| 650 |
_aAntineoplastic Agents _xadverse effects _v _y _z |
||
| 650 |
_aPhenolphthalein _xadverse effects _v _y _z |
||
| 650 |
_aVitamin K _x _v _y _z |
||
| 710 | _a International Agency for Research Cancer | ||
| 710 | _a World Health Organization | ||
| 942 |
_2ddc _BK _cBK |
||
| 999 |
_c414976 _d414976 |
||